Literature DB >> 3903975

Experimental hematogenous infection of subcutaneously implanted foreign bodies.

W Zimmerli, O Zak, K Vosbeck.   

Abstract

Implanted foreign bodies are highly susceptible to pyogenic infection. Whereas infection up to 3 months after surgery is probably due to perioperative bacterial contamination, little is known about the pathogenesis of late prosthetic infections. We employed an animal model to determine whether subcutaneously implanted foreign bodies were susceptible to experimental bacteremia. Tissue cages were implanted into guinea pigs, which were infected at the earliest 4 weeks later by intracardiac injection of Staphylococcus aureus Wood 46. The injection of 2 X 10(6) cfu did not result in any infection. Inoculation of 5 X 10(7) cfu resulted in a bacteremia of 10(2)-10(3) cfu/ml after 5 min and led to 11/26 selective tissue cage infections with no microbiological evidence of infection elsewhere. Higher inocula caused systemic infections with foci in different organs. Rifampin (7.5 mg/kg b.i.d.) was administered for 48 h, starting at different times after infection to establish the best timing for efficacious short-term therapy. When treatment was begun 1 h before or 3 h after inoculation, complete protection was observed, whereas 1/12 and 3/15 tissue cages remained infected when the first dose was not given until 24 h and 48 h, respectively, after inoculation. These experiments illustrate that implanted prostheses are highly susceptible even to bacteremias with low density of microorganisms. Prophylaxis can prevent such infections, whereas delayed short-term treatment may fail.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903975     DOI: 10.3109/inf.1985.17.issue-3.10

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  15 in total

1.  Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin.

Authors:  N Bouchenaki; P E Vaudaux; E Huggler; F A Waldvogel; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 2.  Pathogenesis of implant-associated infection: the role of the host.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Semin Immunopathol       Date:  2011-05-21       Impact factor: 9.623

3.  Timing, dosing and duration of antimicrobial prophylaxis in urology: a study in guinea pigs with special reference to high-risk conditions.

Authors:  T C Gasser; P O Madsen
Journal:  Infection       Date:  1993 Jan-Feb       Impact factor: 3.553

4.  Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection.

Authors:  Christiane Wolz; Christiane Goerke; Regine Landmann; Werner Zimmerli; Ursula Fluckiger
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 5.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

6.  Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. I. Development and initial characterisation of the model.

Authors:  J Dawson; C Rordorf-Adam; T Geiger; H Towbin; S Kunz; H Nguyen; O Zingel; D Chaplin; K Vosbeck
Journal:  Agents Actions       Date:  1993-03

7.  Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.725

8.  Differential effects of prednisolone and indomethacin on zymosan-induced inflammation in a modified murine tissue-chamber model.

Authors:  A O Oluyomi; H Nguyen; H Towbin; J Dawson; K Vosbeck
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

Review 9.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 10.  Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment.

Authors:  Andrej Trampuz; Werner Zimmerli
Journal:  Drugs       Date:  2006       Impact factor: 11.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.